Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_assertion type Assertion NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_head.
- NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_assertion description "[Among patients treated with clopidogrel for percutaneous coronary intervention, carriage of even 1 reduced-function CYP2C19 allele appears to be associated with a significantly increased risk of major adverse cardiovascular events, particularly stent thro]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_provenance.
- NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_assertion evidence source_evidence_literature NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_provenance.
- NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_assertion SIO_000772 20978260 NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_provenance.
- NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_assertion wasDerivedFrom gad-20150221 NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_provenance.
- NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_assertion wasGeneratedBy ECO_0000203 NP187641.RAL0RB5w1fvGq5bc_NmRgEYr8RL-VgpZZvHngJ1ZWHwM8130_provenance.